Company Profiles

driven by the PitchBook Platform

HyperBranch Medical Technology

HyperBranch Medical Technology
2003 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$2M LATEST DEAL AMOUNT
$21.8M TOTAL AMOUNT RAISED
Description

Developer of biosurgical devices designed to reduce the morbidity and mortality of patients undergoing surgery. The company's biosurgical devices provide OcuSeal liquid ocular bandage for direct application on the surface of the eye, Dura Sealant, which is used as an aid in dural repair in cases of cranial and spinal surgeries and tunable hydrogels which confer material properties of biocompatibility with superior tissue adherence, strength and durability, enabling patients to recover faster in cases of tissue damage.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
800-12 Capitola Drive
Durham, NC 27713
United States
+1 (919) 433-3325
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HyperBranch Medical Technology’s full profile, request a free trial.

HyperBranch Medical Technology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 01-Jun-2013 $2M $21.8M Completed Generating Revenue
11. Later Stage VC 04-Jun-2012 00.000 000.00 000.00 Completed Generating Revenue
10. Later Stage VC 20-Oct-2011 00.000 000.00 Completed Generating Revenue
9. Later Stage VC 22-Nov-2010 00.000 000.00 Completed Generating Revenue
8. Later Stage VC (Series A) 19-Apr-2010 00.00 000.00 Completed Generating Revenue
7. Later Stage VC 12-May-2009 00.000 000.00 Completed Generating Revenue
6. Debt - General 02-May-2008 000 00.00 Completed Generating Revenue
5. Debt - General 13-Aug-2007 00.00 00.00 Completed Startup
4. Early Stage VC (Series A) 02-May-2006 000 000 Completed Startup
3. Grant 01-Jan-2006 00000 000 Completed Startup
2. Early Stage VC (Series A) 25-Jan-2005 $6M $6M Completed Startup
1. Grant 01-Jan-2005 $245k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

HyperBranch Medical Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 000,000 00.000000 00 00 00 00 00 0.00
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table request access »

HyperBranch Medical Technology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Durham Capital Lender/Debt Provider Minority 000 0000 000000 0
H.I.G. BioHealth Partners Venture Capital Minority 000 0000 000000 0
The Aurora Funds Venture Capital Minority 000 0000 000000 0

HyperBranch Medical Technology Executive Team (2)

Name Title Board
Seat
Contact
Info
Jeffrey Clark Board of Director, Chief Executive Officer & Chief Operating Officer
Stuart Rogers Vice President, Global Sales & Marketing

HyperBranch Medical Technology Board Members (5)

Name Representing Role Since Contact
Info
Aaron Davidson H.I.G. BioHealth Partners Board Member 000 0000
Christopher Kroeger MD The Aurora Funds Board Member 000 0000
Jefferson Clark The Aurora Funds Board Member 000 0000
Michael Wasserman Ph.D H.I.G. BioHealth Partners Board Member 000 0000
Robert White Self Board Member 000 0000